Evidence map›Paper›PMID 25795433›Full record

ReviewClinical therapeutics2015

Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics.

David T W Wong

Abstract readReview
In one paragraph

Review in Clinical therapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Applicability of Oral Fluid and Dried Blood Spot for Hepatitis B Virus Diagnosis.Canadian journal of gastroenterology & hepatology · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  20. Surveillance for neoplasia in the pancreas.Best practice & research. Clinical gastroenterology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David T W WongDivision of Oral Biology, School of Dentistry; Jonnson Comprehensive Cancer Center, Department of Head and Neck Surgery, David Geffen School of Medicine; School of Engineering, University of California Los Angeles, Los Angeles, California. Electronic address: dtww@ucla.edu.

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Salivary Biomarkers for Sjogren's Syndrome Detection-Definitive ValidationU01DE017593 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2011 to 2014
$4.3M
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer DetectionUH3TR000923 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2015 to 2017
$2.7M
Salivary Proteomic & Genomic Biomarkers for Primary Sjogren's SyndromeR01DE017593 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2006 to 2010
$2.1M
Molecular Determinants of Oral Tongue Cancer MetastasisR01CA139596 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T, ZHOU, XIAOFENG · 2008 to 2012
$1.7M
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer DetectionUH2TR000923 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2013 to 2014
$996k
Molecular Characterization of Parotid Gland TumorsR56DE023241 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2012 to 2012
$211k
NCATS NIH HHS UH2 TR000923NCATS NIH HHS UH2TR000923NCATS NIH HHS UH3 TR000923NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA139596NCI NIH HHS R01CA139596NIDCR NIH HHS R01 DE017593NIDCR NIH HHS R56 DE023241NIDCR NIH HHS R56DE23241NIDCR NIH HHS U01 DE017593NIDCR NIH HHS U01DE17593
6 · The paper itself

Abstract

Saliva is a complex body fluid that comprises secretions from the major and minor salivary glands, nourished by body's vasculature. Although many circulatory molecules (DNA, RNA, and proteins) can also be present in saliva, saliva harbors unique molecular constituents that can be discriminatory for oral and systemic disease screening and detection. Many studies have reported that salivary constituents can discriminate oral diseases (oral cancer and Sjögren's syndrome) and also systemic diseases (lung cancer, breast cancer, pancreatic cancer, and ovarian cancer). Noncoding RNAs (ncRNAs) are emerging new regulators of diverse biological functions, playing important roles in oncogenesis and tumor progression. Indeed, the short size of these molecules makes them stable in different body fluids such as urine, blood, and saliva, being not as susceptible as mRNAs to degradation by RNases. Here, the current status and clinical implications of the ncRNAs present in human saliva are reviewed for translational applications and basic biological research. The development of noninvasive salivary test (based on ncRNAs profiles) for disease detection could have effective applications into the clinical context with a translational significance as emerging molecular biomarkers for non-invasively disease detection, not only by reducing the cost to the health care system but also by benefitting patients.

Indexed as

Biomarkers, TumorFemaleHumansMolecular Diagnostic TechniquesNeoplasmsRNA, UntranslatedSalivaBiomarkers, TumorRNA, Untranslatedbiomarkersbody fluidcancerdiagnosticsnoninvasivenesssaliva

Identifiers

PMID25795433
PMCPMC4395471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.